Infographic | July 15, 2020

Small Molecule Drug Substance Outsourcing Drivers

Source: ISR Reports

In Q4, 2019 ISR surveyed 42 outsourcers from small biopharma companies to find out how they would characterize their company’s main driver for working with CMOs on small molecule drug substance manufacturing work. The vast majority, 86%, reported using CMOs for all of their manufacturing needs.  To learn more about how company size influences outsourcing practices, follow the link to the Small Molecule API CMO Quality Benchmarking: A Look at Small & Emerging Biopharma report preview. 

VIEW THE INFOGRAPHIC!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: